Advancing Efforts In Disease Interception
Description
Ben Wiegand, Global Head of the World Without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent disease or identify it in its...
-- Read more on ScientificAmerican.com
-- Read more on ScientificAmerican.com
More from Scientific American
3y ago41:260